BioSpace

InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot

Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization ...
New York Post

FDA must disclose more COVID-19 vaccine records, US judge rules

U.S. District Judge Mark Pittman ordered the U.S. Food and Drug Administration to produce its "emergency use authorization" file to a group of scientists who wanted to see licensing information that ...
Fierce Pharma

InflaRx to prune headcount by 30%, curb COVID drug spending in bid to advance new favorite asset izicopan

InflaRx had been pursuing development of vilobelimab in other indications beyond COVID, but the company’s hopes for the asset ...
6abc News

FDA halts authorization of Evusheld, citing medication insufficient against viral COVID-19 variants

The US Food and Drug Administration on Thursday halted the emergency use authorization of Evusheld because it does not appear to protect against COVID-19 from viral variants currently circulating in ...
Nasdaq

Invivyd Submits Updated Immunobridging Analysis for Pemivibart to Support EUA Amendment for COVID-19 Treatment

Invivyd, Inc. announced the submission of an updated immunobridging analysis to the FDA, aimed at supporting an amendment to the Emergency Use Authorization (EUA) for its investigational monoclonal ...